Nanophysics has innovative solutions that transcend traditional drug delivery mechanisms. At the nanoscale, materials exhibit unique properties, allowing for precise manipulation and control over drug formulations. Nanoparticles, with dimensions ranging from 1 to 100 nanometers, enable enhanced bioavailability, targeted drug delivery, and improved therapeutic efficacy. These advancements have significant implications for pharmaceutical applications, as nanophysics facilitates the design of drug carriers capable of navigating physiological barriers, such as the blood-brain barrier, enabling the treatment of previously inaccessible conditions.
Moreover, nanophysics enables the customization of drug release profiles, optimizing therapeutic outcomes while minimizing side effects. The interdisciplinary nature of nanophysics in pharmaceuticals underscores its potential to redefine drug development, opening avenues for personalized medicine and novel treatment modalities. As researchers continue to unravel the intricacies of nanoscale phenomena, the integration of nanophysics in pharmaceuticals holds promise for addressing unmet medical needs and fostering a new era of precision medicine.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia